nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—FGF1—Pazopanib—kidney cancer	0.724	1	CbGbCtD
Amlexanox—Aphthous stomatitis—Temsirolimus—kidney cancer	0.00629	0.057	CcSEcCtD
Amlexanox—Aphthous stomatitis—Everolimus—kidney cancer	0.00468	0.0424	CcSEcCtD
Amlexanox—Aphthous stomatitis—Sorafenib—kidney cancer	0.00406	0.0368	CcSEcCtD
Amlexanox—Aphthous stomatitis—Sunitinib—kidney cancer	0.00391	0.0354	CcSEcCtD
Amlexanox—Oropharyngeal pain—Pazopanib—kidney cancer	0.00306	0.0277	CcSEcCtD
Amlexanox—Mouth ulceration—Temsirolimus—kidney cancer	0.00267	0.0242	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Sorafenib—kidney cancer	0.00262	0.0237	CcSEcCtD
Amlexanox—Mouth ulceration—Pazopanib—kidney cancer	0.00251	0.0228	CcSEcCtD
Amlexanox—Oropharyngeal pain—Everolimus—kidney cancer	0.00241	0.0219	CcSEcCtD
Amlexanox—S100A13—renal system—kidney cancer	0.00227	0.154	CbGeAlD
Amlexanox—S100A13—gonad—kidney cancer	0.00204	0.138	CbGeAlD
Amlexanox—Oropharyngeal pain—Sunitinib—kidney cancer	0.00202	0.0183	CcSEcCtD
Amlexanox—Mouth ulceration—Everolimus—kidney cancer	0.00199	0.018	CcSEcCtD
Amlexanox—Liver function test abnormal—Pazopanib—kidney cancer	0.00186	0.0169	CcSEcCtD
Amlexanox—Mouth ulceration—Sorafenib—kidney cancer	0.00172	0.0156	CcSEcCtD
Amlexanox—Throat sore—Paclitaxel—kidney cancer	0.00171	0.0155	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Paclitaxel—kidney cancer	0.00169	0.0153	CcSEcCtD
Amlexanox—Mouth ulceration—Sunitinib—kidney cancer	0.00166	0.015	CcSEcCtD
Amlexanox—Stomatitis—Temsirolimus—kidney cancer	0.00161	0.0146	CcSEcCtD
Amlexanox—Mouth ulceration—Dactinomycin—kidney cancer	0.00157	0.0142	CcSEcCtD
Amlexanox—FGF1—nephron tubule—kidney cancer	0.00154	0.104	CbGeAlD
Amlexanox—Stomatitis—Pazopanib—kidney cancer	0.00152	0.0137	CcSEcCtD
Amlexanox—Liver function test abnormal—Everolimus—kidney cancer	0.00147	0.0133	CcSEcCtD
Amlexanox—PDE4D—cortex of kidney—kidney cancer	0.00141	0.0955	CbGeAlD
Amlexanox—Throat sore—Capecitabine—kidney cancer	0.0014	0.0127	CcSEcCtD
Amlexanox—Mouth ulceration—Vincristine—kidney cancer	0.0014	0.0127	CcSEcCtD
Amlexanox—FGF1—renal system—kidney cancer	0.0014	0.0949	CbGeAlD
Amlexanox—Oropharyngeal discomfort—Capecitabine—kidney cancer	0.00139	0.0126	CcSEcCtD
Amlexanox—Aphthous stomatitis—Doxorubicin—kidney cancer	0.00139	0.0126	CcSEcCtD
Amlexanox—Oropharyngeal pain—Paclitaxel—kidney cancer	0.00135	0.0123	CcSEcCtD
Amlexanox—FGF1—kidney—kidney cancer	0.00135	0.0918	CbGeAlD
Amlexanox—FGF1—cortex of kidney—kidney cancer	0.00132	0.0894	CbGeAlD
Amlexanox—FGF1—cardiac atrium—kidney cancer	0.00125	0.085	CbGeAlD
Amlexanox—Liver function test abnormal—Sunitinib—kidney cancer	0.00123	0.0111	CcSEcCtD
Amlexanox—Stomatitis—Everolimus—kidney cancer	0.0012	0.0108	CcSEcCtD
Amlexanox—Liver function test abnormal—Dactinomycin—kidney cancer	0.00116	0.0105	CcSEcCtD
Amlexanox—Stomatitis—Erlotinib—kidney cancer	0.00116	0.0105	CcSEcCtD
Amlexanox—Mouth ulceration—Paclitaxel—kidney cancer	0.00111	0.0101	CcSEcCtD
Amlexanox—Oropharyngeal pain—Capecitabine—kidney cancer	0.00111	0.0101	CcSEcCtD
Amlexanox—Stomatitis—Sorafenib—kidney cancer	0.00104	0.00941	CcSEcCtD
Amlexanox—Nervous system disorder—Temsirolimus—kidney cancer	0.00103	0.00935	CcSEcCtD
Amlexanox—Stomatitis—Sunitinib—kidney cancer	0.001	0.00905	CcSEcCtD
Amlexanox—Liver function test abnormal—Gemcitabine—kidney cancer	0.000986	0.00893	CcSEcCtD
Amlexanox—Nervous system disorder—Pazopanib—kidney cancer	0.000973	0.00881	CcSEcCtD
Amlexanox—Stomatitis—Dactinomycin—kidney cancer	0.000947	0.00857	CcSEcCtD
Amlexanox—Mouth ulceration—Capecitabine—kidney cancer	0.000914	0.00828	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.000909	0.00823	CcSEcCtD
Amlexanox—Pain—Temsirolimus—kidney cancer	0.000901	0.00815	CcSEcCtD
Amlexanox—Paraesthesia—Pazopanib—kidney cancer	0.000891	0.00807	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000857	0.00775	CcSEcCtD
Amlexanox—Pain—Pazopanib—kidney cancer	0.000848	0.00768	CcSEcCtD
Amlexanox—Stomatitis—Vincristine—kidney cancer	0.000846	0.00766	CcSEcCtD
Amlexanox—Liver function test abnormal—Paclitaxel—kidney cancer	0.000826	0.00748	CcSEcCtD
Amlexanox—Stomatitis—Gemcitabine—kidney cancer	0.000802	0.00726	CcSEcCtD
Amlexanox—Nervous system disorder—Everolimus—kidney cancer	0.000768	0.00696	CcSEcCtD
Amlexanox—PDE4B—cortex of kidney—kidney cancer	0.000743	0.0504	CbGeAlD
Amlexanox—Nervous system disorder—Erlotinib—kidney cancer	0.000741	0.00671	CcSEcCtD
Amlexanox—PDE4B—gonad—kidney cancer	0.000708	0.048	CbGeAlD
Amlexanox—PDE4B—cardiac atrium—kidney cancer	0.000707	0.048	CbGeAlD
Amlexanox—Paraesthesia—Vinblastine—kidney cancer	0.000706	0.00639	CcSEcCtD
Amlexanox—Paraesthesia—Everolimus—kidney cancer	0.000703	0.00637	CcSEcCtD
Amlexanox—Liver function test abnormal—Capecitabine—kidney cancer	0.000678	0.00613	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Everolimus—kidney cancer	0.000676	0.00612	CcSEcCtD
Amlexanox—Pain—Vinblastine—kidney cancer	0.000672	0.00609	CcSEcCtD
Amlexanox—Stomatitis—Paclitaxel—kidney cancer	0.000672	0.00608	CcSEcCtD
Amlexanox—Pain—Everolimus—kidney cancer	0.00067	0.00606	CcSEcCtD
Amlexanox—Nervous system disorder—Sorafenib—kidney cancer	0.000667	0.00604	CcSEcCtD
Amlexanox—Headache—Temsirolimus—kidney cancer	0.00066	0.00597	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000653	0.00591	CcSEcCtD
Amlexanox—Pain—Erlotinib—kidney cancer	0.000646	0.00585	CcSEcCtD
Amlexanox—Nervous system disorder—Sunitinib—kidney cancer	0.000642	0.00581	CcSEcCtD
Amlexanox—Nausea—Temsirolimus—kidney cancer	0.000626	0.00566	CcSEcCtD
Amlexanox—Headache—Pazopanib—kidney cancer	0.000622	0.00563	CcSEcCtD
Amlexanox—Nausea—Pazopanib—kidney cancer	0.000589	0.00534	CcSEcCtD
Amlexanox—Mouth ulceration—Doxorubicin—kidney cancer	0.000589	0.00533	CcSEcCtD
Amlexanox—Paraesthesia—Sunitinib—kidney cancer	0.000588	0.00532	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000587	0.00531	CcSEcCtD
Amlexanox—Pain—Sorafenib—kidney cancer	0.000582	0.00526	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000565	0.00511	CcSEcCtD
Amlexanox—Pain—Sunitinib—kidney cancer	0.00056	0.00507	CcSEcCtD
Amlexanox—Stomatitis—Capecitabine—kidney cancer	0.000551	0.00499	CcSEcCtD
Amlexanox—Nervous system disorder—Vincristine—kidney cancer	0.000543	0.00491	CcSEcCtD
Amlexanox—Pain—Dactinomycin—kidney cancer	0.00053	0.0048	CcSEcCtD
Amlexanox—Nervous system disorder—Gemcitabine—kidney cancer	0.000515	0.00466	CcSEcCtD
Amlexanox—Paraesthesia—Vincristine—kidney cancer	0.000497	0.0045	CcSEcCtD
Amlexanox—Headache—Vinblastine—kidney cancer	0.000493	0.00446	CcSEcCtD
Amlexanox—Headache—Everolimus—kidney cancer	0.000491	0.00444	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Vincristine—kidney cancer	0.000478	0.00433	CcSEcCtD
Amlexanox—Headache—Erlotinib—kidney cancer	0.000474	0.00429	CcSEcCtD
Amlexanox—Pain—Vincristine—kidney cancer	0.000473	0.00428	CcSEcCtD
Amlexanox—Paraesthesia—Gemcitabine—kidney cancer	0.000471	0.00427	CcSEcCtD
Amlexanox—Nausea—Vinblastine—kidney cancer	0.000467	0.00423	CcSEcCtD
Amlexanox—Nausea—Everolimus—kidney cancer	0.000465	0.00421	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000453	0.0041	CcSEcCtD
Amlexanox—Pain—Gemcitabine—kidney cancer	0.000449	0.00406	CcSEcCtD
Amlexanox—Nausea—Erlotinib—kidney cancer	0.000449	0.00406	CcSEcCtD
Amlexanox—Liver function test abnormal—Doxorubicin—kidney cancer	0.000437	0.00395	CcSEcCtD
Amlexanox—Nervous system disorder—Paclitaxel—kidney cancer	0.000431	0.0039	CcSEcCtD
Amlexanox—Headache—Sorafenib—kidney cancer	0.000426	0.00386	CcSEcCtD
Amlexanox—Headache—Sunitinib—kidney cancer	0.00041	0.00371	CcSEcCtD
Amlexanox—Nausea—Sorafenib—kidney cancer	0.000404	0.00366	CcSEcCtD
Amlexanox—Paraesthesia—Paclitaxel—kidney cancer	0.000395	0.00357	CcSEcCtD
Amlexanox—Nausea—Sunitinib—kidney cancer	0.000389	0.00352	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00038	0.00344	CcSEcCtD
Amlexanox—Pain—Paclitaxel—kidney cancer	0.000376	0.0034	CcSEcCtD
Amlexanox—Nausea—Dactinomycin—kidney cancer	0.000368	0.00333	CcSEcCtD
Amlexanox—Stomatitis—Doxorubicin—kidney cancer	0.000355	0.00322	CcSEcCtD
Amlexanox—Nervous system disorder—Capecitabine—kidney cancer	0.000354	0.0032	CcSEcCtD
Amlexanox—Headache—Vincristine—kidney cancer	0.000347	0.00314	CcSEcCtD
Amlexanox—Headache—Gemcitabine—kidney cancer	0.000329	0.00298	CcSEcCtD
Amlexanox—Nausea—Vincristine—kidney cancer	0.000329	0.00298	CcSEcCtD
Amlexanox—Paraesthesia—Capecitabine—kidney cancer	0.000324	0.00293	CcSEcCtD
Amlexanox—Nausea—Gemcitabine—kidney cancer	0.000312	0.00282	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000311	0.00282	CcSEcCtD
Amlexanox—Pain—Capecitabine—kidney cancer	0.000308	0.00279	CcSEcCtD
Amlexanox—Headache—Paclitaxel—kidney cancer	0.000275	0.00249	CcSEcCtD
Amlexanox—Nausea—Paclitaxel—kidney cancer	0.000261	0.00236	CcSEcCtD
Amlexanox—Nervous system disorder—Doxorubicin—kidney cancer	0.000228	0.00206	CcSEcCtD
Amlexanox—Headache—Capecitabine—kidney cancer	0.000226	0.00205	CcSEcCtD
Amlexanox—Nausea—Capecitabine—kidney cancer	0.000214	0.00194	CcSEcCtD
Amlexanox—Paraesthesia—Doxorubicin—kidney cancer	0.000209	0.00189	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000201	0.00182	CcSEcCtD
Amlexanox—Pain—Doxorubicin—kidney cancer	0.000199	0.0018	CcSEcCtD
Amlexanox—Headache—Doxorubicin—kidney cancer	0.000146	0.00132	CcSEcCtD
Amlexanox—Nausea—Doxorubicin—kidney cancer	0.000138	0.00125	CcSEcCtD
Amlexanox—FGF1—Innate Immune System—CDKN1B—kidney cancer	2.77e-05	0.000184	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL2—kidney cancer	2.77e-05	0.000183	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—POMC—kidney cancer	2.76e-05	0.000183	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—PIK3CA—kidney cancer	2.76e-05	0.000183	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FLT1—kidney cancer	2.73e-05	0.000181	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—KRAS—kidney cancer	2.73e-05	0.000181	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—JUNB—kidney cancer	2.72e-05	0.00018	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PAK1—kidney cancer	2.72e-05	0.00018	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—POMC—kidney cancer	2.71e-05	0.00018	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—RAF1—kidney cancer	2.7e-05	0.000179	CbGpPWpGaD
Amlexanox—S100A12—Immune System—JUN—kidney cancer	2.69e-05	0.000178	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CTNNB1—kidney cancer	2.67e-05	0.000177	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—IL2—kidney cancer	2.66e-05	0.000177	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CDKN1B—kidney cancer	2.66e-05	0.000176	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—JUN—kidney cancer	2.64e-05	0.000175	CbGpPWpGaD
Amlexanox—IL3—Immune System—MAPK1—kidney cancer	2.64e-05	0.000175	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CTNNB1—kidney cancer	2.62e-05	0.000174	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PTEN—kidney cancer	2.6e-05	0.000172	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—PTEN—kidney cancer	2.55e-05	0.000169	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TSC2—kidney cancer	2.54e-05	0.000168	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—JUNB—kidney cancer	2.53e-05	0.000168	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PAK1—kidney cancer	2.53e-05	0.000168	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF2—kidney cancer	2.52e-05	0.000167	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN2B—kidney cancer	2.51e-05	0.000166	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—POMC—kidney cancer	2.51e-05	0.000166	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—PIK3CA—kidney cancer	2.51e-05	0.000166	CbGpPWpGaD
Amlexanox—IL3—Immune System—KRAS—kidney cancer	2.49e-05	0.000165	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RAF1—kidney cancer	2.49e-05	0.000165	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RELA—kidney cancer	2.48e-05	0.000164	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ERBB2—kidney cancer	2.46e-05	0.000163	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—PTEN—kidney cancer	2.45e-05	0.000162	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF1R—kidney cancer	2.44e-05	0.000162	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MTOR—kidney cancer	2.43e-05	0.000161	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—IL2—kidney cancer	2.42e-05	0.00016	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF2—kidney cancer	2.4e-05	0.000159	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN2B—kidney cancer	2.39e-05	0.000158	CbGpPWpGaD
Amlexanox—FGF1—Disease—HIF1A—kidney cancer	2.35e-05	0.000156	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—RAF1—kidney cancer	2.35e-05	0.000156	CbGpPWpGaD
Amlexanox—FGF1—Disease—TSC2—kidney cancer	2.35e-05	0.000156	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF1R—kidney cancer	2.32e-05	0.000154	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—IL2—kidney cancer	2.32e-05	0.000154	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HIF1A—kidney cancer	2.31e-05	0.000153	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TSC2—kidney cancer	2.3e-05	0.000152	CbGpPWpGaD
Amlexanox—IL3—Immune System—PIK3CA—kidney cancer	2.29e-05	0.000152	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CDKN1B—kidney cancer	2.28e-05	0.000151	CbGpPWpGaD
Amlexanox—FGF1—Immune System—KIT—kidney cancer	2.25e-05	0.000149	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—RAF1—kidney cancer	2.24e-05	0.000148	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IL2—kidney cancer	2.23e-05	0.000148	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MAPK3—kidney cancer	2.22e-05	0.000147	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF2—kidney cancer	2.22e-05	0.000147	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN2B—kidney cancer	2.21e-05	0.000146	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—IL2—kidney cancer	2.21e-05	0.000146	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KDR—kidney cancer	2.2e-05	0.000146	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MAPK3—kidney cancer	2.18e-05	0.000145	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CCND1—kidney cancer	2.17e-05	0.000144	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—JUN—kidney cancer	2.17e-05	0.000144	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CTNNB1—kidney cancer	2.15e-05	0.000143	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF1R—kidney cancer	2.15e-05	0.000142	CbGpPWpGaD
Amlexanox—S100A12—Immune System—MAPK1—kidney cancer	2.12e-05	0.00014	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—IL2—kidney cancer	2.11e-05	0.00014	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PTEN—kidney cancer	2.1e-05	0.000139	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—MAPK1—kidney cancer	2.08e-05	0.000138	CbGpPWpGaD
Amlexanox—FGF1—Disease—APC—kidney cancer	2.07e-05	0.000137	CbGpPWpGaD
Amlexanox—FGF1—Disease—KIT—kidney cancer	2.07e-05	0.000137	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF2—kidney cancer	2.07e-05	0.000137	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—RAF1—kidney cancer	2.07e-05	0.000137	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDH1—kidney cancer	2.07e-05	0.000137	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN2B—kidney cancer	2.06e-05	0.000137	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—IL2—kidney cancer	2.04e-05	0.000135	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KIT—kidney cancer	2.03e-05	0.000135	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APC—kidney cancer	2.03e-05	0.000135	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HIF1A—kidney cancer	2.01e-05	0.000133	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—IL2—kidney cancer	2e-05	0.000133	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF1R—kidney cancer	2e-05	0.000133	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TSC2—kidney cancer	2e-05	0.000133	CbGpPWpGaD
Amlexanox—S100A12—Immune System—KRAS—kidney cancer	2e-05	0.000132	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—KRAS—kidney cancer	1.96e-05	0.00013	CbGpPWpGaD
Amlexanox—FGF1—Disease—BRAF—kidney cancer	1.95e-05	0.000129	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—MAPK3—kidney cancer	1.95e-05	0.000129	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—POMC—kidney cancer	1.93e-05	0.000128	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KDR—kidney cancer	1.92e-05	0.000127	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HIF1A—kidney cancer	1.91e-05	0.000127	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—BRAF—kidney cancer	1.91e-05	0.000126	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TSC2—kidney cancer	1.91e-05	0.000126	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VEGFA—kidney cancer	1.9e-05	0.000126	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—KRAS—kidney cancer	1.88e-05	0.000125	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—IL2—kidney cancer	1.86e-05	0.000123	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—MAPK1—kidney cancer	1.85e-05	0.000123	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PIK3CA—kidney cancer	1.84e-05	0.000122	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KDR—kidney cancer	1.83e-05	0.000121	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—PIK3CA—kidney cancer	1.8e-05	0.000119	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAPK3—kidney cancer	1.79e-05	0.000119	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—PIK3CA—kidney cancer	1.77e-05	0.000117	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KIT—kidney cancer	1.77e-05	0.000117	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APC—kidney cancer	1.77e-05	0.000117	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HIF1A—kidney cancer	1.77e-05	0.000117	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TSC2—kidney cancer	1.76e-05	0.000117	CbGpPWpGaD
Amlexanox—FGF1—Immune System—RAF1—kidney cancer	1.76e-05	0.000117	CbGpPWpGaD
Amlexanox—FGF1—Immune System—RELA—kidney cancer	1.75e-05	0.000116	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—KRAS—kidney cancer	1.75e-05	0.000116	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MYC—kidney cancer	1.74e-05	0.000116	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ERBB2—kidney cancer	1.74e-05	0.000116	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—PIK3CA—kidney cancer	1.73e-05	0.000115	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MTOR—kidney cancer	1.72e-05	0.000114	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD4—kidney cancer	1.72e-05	0.000114	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MAPK1—kidney cancer	1.71e-05	0.000113	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—MAPK3—kidney cancer	1.69e-05	0.000112	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KDR—kidney cancer	1.69e-05	0.000112	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—POMC—kidney cancer	1.68e-05	0.000111	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KIT—kidney cancer	1.68e-05	0.000111	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APC—kidney cancer	1.68e-05	0.000111	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—BRAF—kidney cancer	1.66e-05	0.00011	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HIF1A—kidney cancer	1.65e-05	0.000109	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TSC2—kidney cancer	1.64e-05	0.000109	CbGpPWpGaD
Amlexanox—FGF1—Disease—RAF1—kidney cancer	1.63e-05	0.000108	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDKN1B—kidney cancer	1.61e-05	0.000107	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—MAPK3—kidney cancer	1.61e-05	0.000107	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—KRAS—kidney cancer	1.61e-05	0.000107	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—MAPK1—kidney cancer	1.61e-05	0.000107	CbGpPWpGaD
Amlexanox—FGF1—Disease—ERBB2—kidney cancer	1.61e-05	0.000107	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—PIK3CA—kidney cancer	1.61e-05	0.000106	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—POMC—kidney cancer	1.6e-05	0.000106	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RAF1—kidney cancer	1.59e-05	0.000106	CbGpPWpGaD
Amlexanox—FGF1—Disease—MTOR—kidney cancer	1.59e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RELA—kidney cancer	1.59e-05	0.000105	CbGpPWpGaD
Amlexanox—FGF1—Disease—CD4—kidney cancer	1.59e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—BRAF—kidney cancer	1.58e-05	0.000105	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL2—kidney cancer	1.58e-05	0.000105	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ERBB2—kidney cancer	1.58e-05	0.000104	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KDR—kidney cancer	1.58e-05	0.000104	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—kidney cancer	1.57e-05	0.000104	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KIT—kidney cancer	1.56e-05	0.000103	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APC—kidney cancer	1.56e-05	0.000103	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MTOR—kidney cancer	1.56e-05	0.000103	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—PIK3CA—kidney cancer	1.54e-05	0.000102	CbGpPWpGaD
Amlexanox—FGF1—Immune System—JUN—kidney cancer	1.54e-05	0.000102	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—MAPK1—kidney cancer	1.53e-05	0.000102	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CTNNB1—kidney cancer	1.53e-05	0.000101	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—KRAS—kidney cancer	1.52e-05	0.000101	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—MAPK3—kidney cancer	1.49e-05	9.88e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDKN1B—kidney cancer	1.49e-05	9.88e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PTEN—kidney cancer	1.49e-05	9.85e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—POMC—kidney cancer	1.48e-05	9.82e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PIK3CA—kidney cancer	1.48e-05	9.81e-05	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—PIK3CA—kidney cancer	1.47e-05	9.71e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—BRAF—kidney cancer	1.46e-05	9.7e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDKN1B—kidney cancer	1.46e-05	9.68e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APC—kidney cancer	1.45e-05	9.62e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KIT—kidney cancer	1.45e-05	9.62e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—KRAS—kidney cancer	1.45e-05	9.6e-05	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—kidney cancer	1.43e-05	9.49e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IL2—kidney cancer	1.43e-05	9.47e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—MAPK1—kidney cancer	1.42e-05	9.4e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—CTNNB1—kidney cancer	1.41e-05	9.33e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PIK3CA—kidney cancer	1.4e-05	9.26e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CCND1—kidney cancer	1.39e-05	9.23e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—JUN—kidney cancer	1.39e-05	9.21e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RAF1—kidney cancer	1.39e-05	9.19e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—POMC—kidney cancer	1.38e-05	9.16e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RELA—kidney cancer	1.38e-05	9.15e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CTNNB1—kidney cancer	1.38e-05	9.14e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTEN—kidney cancer	1.37e-05	9.09e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ERBB2—kidney cancer	1.37e-05	9.09e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—BRAF—kidney cancer	1.36e-05	9.04e-05	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—PIK3CA—kidney cancer	1.36e-05	8.98e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MTOR—kidney cancer	1.35e-05	8.98e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTEN—kidney cancer	1.34e-05	8.91e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—KRAS—kidney cancer	1.34e-05	8.88e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PIK3CA—kidney cancer	1.33e-05	8.82e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RAF1—kidney cancer	1.32e-05	8.75e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RELA—kidney cancer	1.32e-05	8.71e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ERBB2—kidney cancer	1.31e-05	8.66e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MTOR—kidney cancer	1.29e-05	8.54e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN1B—kidney cancer	1.27e-05	8.42e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAPK3—kidney cancer	1.27e-05	8.42e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IL2—kidney cancer	1.24e-05	8.24e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PIK3CA—kidney cancer	1.23e-05	8.16e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RAF1—kidney cancer	1.22e-05	8.1e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RELA—kidney cancer	1.22e-05	8.06e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—kidney cancer	1.21e-05	8.05e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CCND1—kidney cancer	1.21e-05	8.04e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—JUN—kidney cancer	1.21e-05	8.02e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN1B—kidney cancer	1.21e-05	8.02e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ERBB2—kidney cancer	1.21e-05	8.01e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—MAPK1—kidney cancer	1.21e-05	8.01e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CTNNB1—kidney cancer	1.2e-05	7.96e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MTOR—kidney cancer	1.19e-05	7.9e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IL2—kidney cancer	1.18e-05	7.85e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAPK3—kidney cancer	1.17e-05	7.77e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTEN—kidney cancer	1.17e-05	7.76e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CCND1—kidney cancer	1.15e-05	7.65e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—JUN—kidney cancer	1.15e-05	7.63e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAPK3—kidney cancer	1.15e-05	7.61e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CTNNB1—kidney cancer	1.14e-05	7.57e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—KRAS—kidney cancer	1.14e-05	7.56e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MYC—kidney cancer	1.14e-05	7.56e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RAF1—kidney cancer	1.14e-05	7.55e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RELA—kidney cancer	1.13e-05	7.52e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ERBB2—kidney cancer	1.13e-05	7.47e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN1B—kidney cancer	1.12e-05	7.42e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MYC—kidney cancer	1.12e-05	7.4e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—MAPK1—kidney cancer	1.12e-05	7.39e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTEN—kidney cancer	1.11e-05	7.38e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MTOR—kidney cancer	1.11e-05	7.37e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IL2—kidney cancer	1.1e-05	7.26e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MAPK1—kidney cancer	1.09e-05	7.24e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CCND1—kidney cancer	1.07e-05	7.08e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—JUN—kidney cancer	1.07e-05	7.06e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CTNNB1—kidney cancer	1.06e-05	7.01e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—kidney cancer	1.06e-05	7.01e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—KRAS—kidney cancer	1.05e-05	6.98e-05	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PIK3CA—kidney cancer	1.05e-05	6.95e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN1B—kidney cancer	1.04e-05	6.92e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—KRAS—kidney cancer	1.03e-05	6.84e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTEN—kidney cancer	1.03e-05	6.83e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IL2—kidney cancer	1.02e-05	6.77e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—kidney cancer	1.01e-05	6.67e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK3—kidney cancer	1e-05	6.63e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CCND1—kidney cancer	9.96e-06	6.6e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—JUN—kidney cancer	9.94e-06	6.58e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CTNNB1—kidney cancer	9.86e-06	6.53e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MYC—kidney cancer	9.73e-06	6.45e-05	CbGpPWpGaD
Amlexanox—FGF1—Disease—PIK3CA—kidney cancer	9.69e-06	6.42e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTEN—kidney cancer	9.61e-06	6.37e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK3—kidney cancer	9.52e-06	6.31e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MAPK1—kidney cancer	9.52e-06	6.31e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PIK3CA—kidney cancer	9.49e-06	6.29e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—kidney cancer	9.31e-06	6.17e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MYC—kidney cancer	9.26e-06	6.13e-05	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—kidney cancer	9.18e-06	6.08e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MAPK1—kidney cancer	9.06e-06	6e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—KRAS—kidney cancer	8.99e-06	5.96e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK3—kidney cancer	8.81e-06	5.84e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—kidney cancer	8.68e-06	5.75e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MYC—kidney cancer	8.57e-06	5.68e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—KRAS—kidney cancer	8.56e-06	5.67e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MAPK1—kidney cancer	8.38e-06	5.55e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PIK3CA—kidney cancer	8.26e-06	5.47e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK3—kidney cancer	8.21e-06	5.44e-05	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—kidney cancer	7.99e-06	5.29e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MYC—kidney cancer	7.99e-06	5.29e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—KRAS—kidney cancer	7.92e-06	5.24e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PIK3CA—kidney cancer	7.86e-06	5.21e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MAPK1—kidney cancer	7.82e-06	5.18e-05	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—kidney cancer	7.61e-06	5.04e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—KRAS—kidney cancer	7.38e-06	4.89e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PIK3CA—kidney cancer	7.27e-06	4.82e-05	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—kidney cancer	7.04e-06	4.66e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PIK3CA—kidney cancer	6.78e-06	4.49e-05	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—kidney cancer	6.56e-06	4.35e-05	CbGpPWpGaD
